GRAIL

GRAL - GRAIL • Financials

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
01/2023
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
93
-1,357
-
L
L
-7,775
L
-97
-
-693
-13
464
-706
0
0
-
-
12/2024
126
-2,031
-
L
L
2,503
L
-763
-
-663
-5
1,244
-668
0
0
-
-
12/2025
147
-406
-
L
L
2,578
L
-904
-
-357
-1
423
-358
0
0
-
-